- Home
- TLSI vs MPAA Comparison
TLSI vs MPAA Comparison
Compare TLSI & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | MPAA |
|---|---|---|
| Founded | 2010 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 257.8M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | TLSI | MPAA |
|---|---|---|
| Price | $7.26 | $12.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $10.67 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 175.5K | 164.8K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $40,207,000.00 | ★ $789,115,000.00 |
| Revenue This Year | $55.06 | $10.44 |
| Revenue Next Year | $46.04 | $4.88 |
| P/E Ratio | ★ N/A | $113.51 |
| Revenue Growth | ★ 49.52 | 6.72 |
| 52 Week Low | $3.42 | $5.38 |
| 52 Week High | $7.70 | $18.12 |
Technical Indicators
Market Signals| Indicator | TLSI | MPAA |
|---|---|---|
| Relative Strength Index (RSI) | 68.96 | 40.82 |
| Support Level | $6.06 | $12.65 |
| Resistance Level | $7.70 | $14.22 |
| Average True Range (ATR) | 0.58 | 0.63 |
| MACD | 0.07 | 0.12 |
| Stochastic Oscillator | 81.08 | 11.56 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.